Chief Technologist, Synthetic Therapeutics: Oligos

Chief Technologist, Synthetic Therapeutics: Oligos

Full-Time 42750 - 52250 Β£ / year (est.) No working from home possible
Hyper Recruitment Solutions

At a Glance

  • Tasks: Lead innovative projects in synthetic therapeutics and shape the future of peptide technology.
  • Company: Join a leading Glasgow facility at the forefront of scientific advancement.
  • Benefits: Competitive salary, potential for permanent role, and opportunity to lead cutting-edge research.
  • Why this job: Make a real impact in the biotech field and drive groundbreaking solutions.
  • Qualifications: Expertise in synthetic therapeutics and strong leadership skills.

The predicted salary is between 42750 - 52250 Β£ per year.

Hyper Recruitment Solutions is seeking a Chief Technologist - Synthetic Therapeutics to join a leading Glasgow facility on a 20-month fixed-term contract, with potential to become permanent. This newly created role offers the chance to build and lead a cutting-edge capability in peptides, oligonucleotides, and oligo conjugation, shaping strategy and delivering commercially viable solutions. You will act as the technical expert, translate scientific insights into deliverable plans, and represent.

Chief Technologist, Synthetic Therapeutics: Oligos employer: Hyper Recruitment Solutions

Join a leading provider of advanced scientific instrumentation where you can thrive as a Field Service Engineer in a dynamic and innovative environment. Enjoy the benefits of ongoing training, professional development, and a supportive team culture that prioritises flexibility and career progression. With the opportunity to work with cutting-edge technology across the South and Central regions, this role offers a rewarding experience for those passionate about science and engineering.

Hyper Recruitment Solutions

Contact Details:

Hyper Recruitment Solutions Recruitment Team

We think you need these skills to ace Chief Technologist, Synthetic Therapeutics: Oligos

Technical Expertise in Synthetic Therapeutics
Peptide Chemistry
Oligonucleotide Synthesis
Oligo Conjugation
Strategic Planning
Commercial Viability Assessment
Scientific Insight Translation